Flaxseed-enriched diets change milk concentration of the antimicrobial danofloxacin in sheep.

about

Flaxseed-enriched diets change milk concentration of the antimicrobial danofloxacin in sheep.

Item

http://www.wikidata.org/entity/Q48042900

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Flaxseed-enriched diets change ...... crobial danofloxacin in sheep.

@en

Flaxseed-enriched diets change ...... crobial danofloxacin in sheep.

@nl

type

Item

label

Flaxseed-enriched diets change ...... crobial danofloxacin in sheep.

@en

Flaxseed-enriched diets change ...... crobial danofloxacin in sheep.

@nl

prefLabel

Flaxseed-enriched diets change ...... crobial danofloxacin in sheep.

@en

Flaxseed-enriched diets change ...... crobial danofloxacin in sheep.

@nl

P1476

Flaxseed-enriched diets change ...... crobial danofloxacin in sheep.

@en

P2093

Dafne García-Mateos

http://www.w3.org/2001/XMLSchema#string

Jon Andoni Otero

http://www.w3.org/2001/XMLSchema#string

Rocío García-Villalba

http://www.w3.org/2001/XMLSchema#string

P2860

Cross-sectional prospective survey to study indication-based usage of antimicrobials in animals: results of use in cattle.

Flax and flaxseed oil: an ancient medicine & modern functional food.

Adverse drug reactions in veterinary patients associated with drug transporters.

Effect of administration route and dose escalation on plasma and intestinal concentrations of enrofloxacin and ciprofloxacin in broiler chickens.

Flaxseed-a potential functional food source

Residues of chlortetracycline, doxycycline and sulfadiazine-trimethoprim in intestinal content and feces of pigs due to cross-contamination of feed

Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response.

Veterinary pharmacology: history, current status and future prospects.

Recent advances in research on lignans and neolignans.

The need for human breast cancer resistance protein substrate and inhibition evaluation in drug discovery and development: why, when, and how?

P2888

s12917-018-1341-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12917-018-1341-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Juan Carlos Espín

Gracia Merino

Ana I. Alvarez

Indira Alvarez-Fernández

P577

2018-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100403276

http://www.w3.org/2001/XMLSchema#string

P698

29334949

http://www.w3.org/2001/XMLSchema#string

P932

5769330

http://www.w3.org/2001/XMLSchema#string